SCHEMBL1736217

SCHEMBL1736217

Cc1c(C)n(Cc2cccc(Cl)c2)c2c(N(C)Cc3ccc(F)cc3)nc(Cl)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.40
TP53 P04637 3/20 0.40
GNRHR P30968 1/20 0.38
LMNA P02545 4/20 0.37
HTT P42858 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
MAOB P27338 1/20 0.37
HTR6 P50406 1/20 0.37
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 2/20 0.36
CSF1R P07333 1/20 0.36
CLPP Q16740 1/20 0.35
MAT2A P31153 1/20 0.35
TSHR P16473 2/20 0.35
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1736914 0.93 MAPT (0.39) HTTKDM4EMAPTSMN1; SMN2MEN1
SCHEMBL1737285 0.89 POLB (0.37) POLBTP53GNRHRLMNAHTT
SCHEMBL1738855 0.81 CYP1A2 (0.35) POLBLMNAHTTKDM4EHPGD
SCHEMBL1736930 0.80 ALDH1A1 (0.39) POLBHTTKDM4EHPGDMAPT
SCHEMBL1737983 0.80 GRIN2A (0.40) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL3183231 0.79 CYP3A4 (0.43) POLBTP53GNRHRLMNAHTT
SCHEMBL3182164 0.79 GRM2 (0.41) LMNAMAPTCSF1R
Hydrochloric Acid SCHEMBL3182100 0.77 MAPT (0.41) KDM4EHTR6MAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL1737443 0.77 CSF1R (0.46) POLBTP53HTTKDM4EGAA
Hydrochloric Acid SCHEMBL1734941 0.76 FABP4 (0.41) POLBTP53LMNAHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188114-B2 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2012-05-29 US claimed
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2010-03-18 US claimed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US claimed
US-8188114-B2 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2012-05-29 US disclosed
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP disclosed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US disclosed
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2010-03-18 US disclosed
US-7662832-B2 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-02-16 US disclosed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H POLB 3262/4885TP53 2941/4885GNRHR 3811/4885
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H POLB 3262/4885TP53 2941/4885GNRHR 3811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.